requir heparin arteri venou thrombolysi recombin tissue-typ plasminogen activ effect concomit intraven IV heparin u/kg bolu u/kg/h efficaci arteri venou thrombolysi IV recombin tissue-typ plasminogen activ rt-pa mg/kg hour combin femor arteri venou thrombosi model dog arteri model high-grad stenosi endotheli damag thrombot occlus venou model blood clot dose-find pilot studi dog prospect studi anim mg/kg IV salicyl acid asa combin rt-pa heparin group earli minut arteri reperfus dog minut dog persist occlus dog rt-pa group II earli reperfus dog reflow dog persist occlus dog reocclus reperfus dog group reperfus dog group II signific venou clot lysi mean sem group group II templat time group minut baselin minut minut group II minut minut system fibrinogen deplet concommit use heparin rt-pa acceler arteri reperfus venou thrombolysi dog asa result random prospect studi design bodi experiment clinic evid thrombolyt therapi rt-pa concomit adjunct IV heparin optim efficaci face treatment asa 